Over 1,000 American Women Sue Pfizer Over Brain Tumors

A class-action lawsuit has been filed in the United States against the pharmaceutical corporation Pfizer, in which more than a thousand women claim that the popular contraceptive Depo-Provera caused them to develop brain tumors. The main diagnosis among the plaintiffs is intracranial meningioma — a rare but serious disease that affects the membranes of the brain and often leads to irreversible consequences.

One of the first to speak publicly was Louisiana resident Robin Phillip. She stated that after several years of using the drug, she developed a meningioma that caused blindness in her left eye and partial loss of mobility.

Attorney Ellen Relkin, representing the victims, said that all the women suffered similar consequences: “All of these women were diagnosed with meningiomas. Many underwent surgery, some are undergoing radiation therapy. Their lives have changed forever.”

According to lawyers, the manufacturer failed to warn patients about the potential dangers of long-term use. Depo-Provera, which contains the synthetic progestin medroxyprogesterone, was widely used as a convenient contraceptive method, administered by injection every three months.

Scientists had previously expressed concerns about a possible link between hormonal drugs and the growth of meningiomas. However, Pfizer had for years maintained that its product was safe and had passed all required clinical trials.

Attorneys are now seeking disclosure of the company’s internal documents to determine whether the manufacturer was aware of potential risks. Experts suggest that the lawsuit could become one of the largest cases against a pharmaceutical corporation in recent years if the court finds a causal link between the drug and the illnesses.

Pfizer has not yet provided an official response to the allegations, stating only that it “always puts patient safety first” and intends to “defend the scientific validity of its products.”